172 related articles for article (PubMed ID: 34073974)
21. Expression of CD44, CD24 and ESA in pancreatic adenocarcinoma cell lines varies with local microenvironment.
Wei HJ; Yin T; Zhu Z; Shi PF; Tian Y; Wang CY
Hepatobiliary Pancreat Dis Int; 2011 Aug; 10(4):428-34. PubMed ID: 21813394
[TBL] [Abstract][Full Text] [Related]
22. Interactions of Renal-Clearable Gold Nanoparticles with Tumor Microenvironments: Vasculature and Acidity Effects.
Yu M; Zhou C; Liu L; Zhang S; Sun S; Hankins JD; Sun X; Zheng J
Angew Chem Int Ed Engl; 2017 Apr; 56(15):4314-4319. PubMed ID: 28295960
[TBL] [Abstract][Full Text] [Related]
23. Gold nanoparticle delivery to solid tumors: a multiparametric study on particle size and the tumor microenvironment.
Izci M; Maksoudian C; Gonçalves F; Aversa L; Salembier R; Sargsian A; Pérez Gilabert I; Chu T; Rios Luci C; Bolea-Fernandez E; Nittner D; Vanhaecke F; Manshian BB; Soenen SJ
J Nanobiotechnology; 2022 Dec; 20(1):518. PubMed ID: 36494816
[TBL] [Abstract][Full Text] [Related]
24. Reviewing two decades of nanomedicine implementations in targeted treatment and diagnosis of pancreatic cancer: An emphasis on state of art.
El-Zahaby SA; Elnaggar YSR; Abdallah OY
J Control Release; 2019 Jan; 293():21-35. PubMed ID: 30445002
[TBL] [Abstract][Full Text] [Related]
25. Physiological relevance of in-vitro cell-nanoparticle interaction studies as a predictive tool in cancer nanomedicine research.
Boinapalli Y; Shankar Pandey R; Singh Chauhan A; Sudheesh MS
Int J Pharm; 2023 Feb; 632():122579. PubMed ID: 36603671
[TBL] [Abstract][Full Text] [Related]
26. From Passive Targeting to Personalized Nanomedicine: Multidimensional Insights on Nanoparticles' Interaction with the Tumor Microenvironment.
Sebak AA; El-Shenawy BM; El-Safy S; El-Shazly M
Curr Pharm Biotechnol; 2021; 22(11):1444-1465. PubMed ID: 33308126
[TBL] [Abstract][Full Text] [Related]
27. Cu-doped cerium oxide-based nanomedicine for tumor microenvironment-stimulative chemo-chemodynamic therapy with minimal side effects.
Cheng F; Wang S; Zheng H; Yang S; Zhou L; Liu K; Zhang Q; Zhang H
Colloids Surf B Biointerfaces; 2021 Sep; 205():111878. PubMed ID: 34058693
[TBL] [Abstract][Full Text] [Related]
28. Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells.
Zhu ZW; Friess H; Wang L; Bogardus T; Korc M; Kleeff J; Büchler MW
Clin Cancer Res; 2001 Jan; 7(1):105-12. PubMed ID: 11205897
[TBL] [Abstract][Full Text] [Related]
29. Lactoferrin/Hyaluronic acid double-coated lignosulfonate nanoparticles of quinacrine as a controlled release biodegradable nanomedicine targeting pancreatic cancer.
Etman SM; Abdallah OY; Mehanna RA; Elnaggar YSR
Int J Pharm; 2020 Mar; 578():119097. PubMed ID: 32032904
[TBL] [Abstract][Full Text] [Related]
30. A Tumor Microenvironment Destroyer for Efficient Cancer Suppression.
Yao H; Xu K; Zhou J; Zhou L; Wei S
ACS Biomater Sci Eng; 2020 Jan; 6(1):450-462. PubMed ID: 33463237
[TBL] [Abstract][Full Text] [Related]
31. Salinomycin nanoparticles interfere with tumor cell growth and the tumor microenvironment in an orthotopic model of pancreatic cancer.
Daman Z; Faghihi H; Montazeri H
Drug Dev Ind Pharm; 2018 Sep; 44(9):1434-1442. PubMed ID: 29619850
[TBL] [Abstract][Full Text] [Related]
32. A Tumor-Penetrating Nanomedicine Improves the Chemoimmunotherapy of Pancreatic Cancer.
Tong QS; Miao WM; Huang H; Luo JQ; Liu R; Huang YC; Zhao DK; Shen S; Du JZ; Wang J
Small; 2021 Jul; 17(29):e2101208. PubMed ID: 34145747
[TBL] [Abstract][Full Text] [Related]
33. An innovative NRF2 nano-modulator induces lung cancer ferroptosis and elicits an immunostimulatory tumor microenvironment.
Hsieh CH; Hsieh HC; Shih FS; Wang PW; Yang LX; Shieh DB; Wang YC
Theranostics; 2021; 11(14):7072-7091. PubMed ID: 34093872
[TBL] [Abstract][Full Text] [Related]
34. Intracellular uptake, transport, and processing of gold nanostructures.
Chithrani DB
Mol Membr Biol; 2010 Oct; 27(7):299-311. PubMed ID: 20929337
[TBL] [Abstract][Full Text] [Related]
35. Using Gold Nanoparticles To Disrupt the Tumor Microenvironment: An Emerging Therapeutic Strategy.
Melamed JR; Riley RS; Valcourt DM; Day ES
ACS Nano; 2016 Dec; 10(12):10631-10635. PubMed ID: 28024339
[TBL] [Abstract][Full Text] [Related]
36. Biological nanoparticles carrying the Hmda-7 gene are effective in inhibiting pancreatic cancer in vitro and in vivo.
Zhu Q; Pan X; Sun Y; Wang Z; Liu F; Li A; Zhao Z; Wang Y; Li K; Mi L
PLoS One; 2017; 12(10):e0185507. PubMed ID: 28985230
[TBL] [Abstract][Full Text] [Related]
37. Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment.
Wei T; Song J; Liang K; Li L; Mo X; Huang Z; Chen G; Mao N; Yang J
J Cancer Res Clin Oncol; 2021 Apr; 147(4):1049-1064. PubMed ID: 33387038
[TBL] [Abstract][Full Text] [Related]
38. Core-shell nanoparticles suppress metastasis and modify the tumour-supportive activity of cancer-associated fibroblasts.
Kovács D; Igaz N; Marton A; Rónavári A; Bélteky P; Bodai L; Spengler G; Tiszlavicz L; Rázga Z; Hegyi P; Vizler C; Boros IM; Kónya Z; Kiricsi M
J Nanobiotechnology; 2020 Jan; 18(1):18. PubMed ID: 31964403
[TBL] [Abstract][Full Text] [Related]
39. Nanotherapy Targeting the Tumor Microenvironment.
Gong BS; Wang R; Xu HX; Miao MY; Yao ZZ
Curr Cancer Drug Targets; 2019; 19(7):525-533. PubMed ID: 30569855
[TBL] [Abstract][Full Text] [Related]
40. Gold nanoparticles prepared by laser ablation in aqueous biocompatible solutions: assessment of safety and biological identity for nanomedicine applications.
Correard F; Maximova K; Estève MA; Villard C; Roy M; Al-Kattan A; Sentis M; Gingras M; Kabashin AV; Braguer D
Int J Nanomedicine; 2014; 9():5415-30. PubMed ID: 25473280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
